Digestive Diseases and Sciences

, Volume 59, Issue 1, pp 108–116 | Cite as

No Significant Effects of Smoking or Alcohol Consumption on Risk of Barrett’s Esophagus

  • Aaron P. Thrift
  • Jennifer R. Kramer
  • Peter A. Richardson
  • Hashem B. El-Serag
Original Article



Smoking, but not higher alcohol consumption, is associated with increased risk of esophageal adenocarcinoma (EAC) and progression from Barrett’s esophagus (BE) to EAC. However, it is still unclear whether smoking or alcohol is implicated in the development of BE.


To evaluate the associations between smoking, alcohol and the risk of BE.


The study included eligible patients scheduled for elective esophagogastroduodenoscopy (EGD) and a sample of patients eligible for screening colonoscopy recruited from primary care clinics. We compared 258 patients with definitive BE with two separate control groups: 453 patients from the primary care group (“colonoscopy controls”) and 1,145 patients from the elective EGD group (“endoscopy controls”) with no endoscopic or histopathologic BE. We calculated odds ratios (OR) and 95 % confidence intervals (95 % CI) using multivariable logistic regression models.


Seventy-seven percent of BE cases, 75 % of colonoscopy controls and 72 % of endoscopy controls were ever smokers. Of these, approximately 45 % were current smokers. Overall, 91 % of study participants were ex or current alcohol drinkers, with the majority drinking beer. We found no association between various measure of smoking exposure (status, intensity, age at initiation, duration, pack-years and cessation) and risk of BE. Alcohol consumption was not associated with increased risk of BE. Conversely, moderate intake was associated with lower risk (14 to <28 drinks/week, OR 0.39, 95 % CI 0.15–1.00).


Smoking and alcohol were not strong or consistent risk factors for BE. The likely role of smoking in increasing risk of EAC is through promoting progression from BE to cancer.


Alcohol Barrett’s esophagus Epidemiology Risk factors Smoking 

Supplementary material

10620_2013_2892_MOESM1_ESM.docx (37 kb)
Supplementary material 1 (DOCX 36 kb)


  1. 1.
    Hvid-Jensen F, Pedersen L, Drewes AM, Sorensen HT, Funch-Jensen P. Incidence of adenocarcinoma among patients with Barrett’s esophagus. N Engl J Med. 2011;365:1375–1383.PubMedCrossRefGoogle Scholar
  2. 2.
    Sikkema M, De Jonge PJ, Steyerberg EW, Kuipers EJ. Risk of esophageal adenocarcinoma and mortality in patients with Barrett’s esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2010;8:235–244.PubMedCrossRefGoogle Scholar
  3. 3.
    Bhat S, Coleman HG, Yousef F, et al. Risk of malignant progression in Barrett’s esophagus patients: results from a large population-based study. J Natl Cancer Inst. 2011;103:1049–1057.PubMedCrossRefGoogle Scholar
  4. 4.
    Desai TK, Krishnan K, Samala N, et al. The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett’s oesophagus: a meta-analysis. Gut. 2012;61:970–976.PubMedCrossRefGoogle Scholar
  5. 5.
    Pohl H, Welch HG. The role of overdiagnosis and reclassification in the marked increase of esophageal adenocarcinoma incidence. J Natl Cancer Inst. 2005;97:142–146.PubMedCrossRefGoogle Scholar
  6. 6.
    Thrift AP, Whiteman DC. The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends. Ann Oncol. 2012;23:3155–3162.PubMedCrossRefGoogle Scholar
  7. 7.
    Polednak AP. Trends in survival for both histologic types of esophageal cancer in US surveillance, epidemiology and end results areas. Int J Cancer. 2003;105:98–100.PubMedCrossRefGoogle Scholar
  8. 8.
    Wang KK, Sampliner RE. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett’s esophagus. Am J Gastroenterol. 2008;103:788–797.PubMedCrossRefGoogle Scholar
  9. 9.
    Thrift AP, Kramer JR, Qureshi Z, Richardson PA, El-Serag HB. Age at onset of GERD symptoms predicts risk of Barrett’s esophagus. Am J Gastroenterol. 2013;108:915–922.PubMedCrossRefGoogle Scholar
  10. 10.
    Kubo A, Cook MB, Shaheen NJ, et al. Sex-specific associations between body mass index, waist circumference and the risk of Barrett’s oesophagus: a pooled analysis from the international BEACON consortium. Gut. 2013. doi:10.1136/gutjnl-2012-303753.
  11. 11.
    Anderson LA, Johnston BT, Watson RG, et al. Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence. Cancer Res. 2006;66:4975–4982.PubMedCrossRefGoogle Scholar
  12. 12.
    Cook MB, Kamangar F, Whiteman DC, et al. Cigarette smoking and adenocarcinomas of the esophagus and esophagogastric junction: a pooled analysis from the international BEACON consortium. J Natl Cancer Inst. 2010;102:1344–1353.PubMedCrossRefGoogle Scholar
  13. 13.
    Cook MB, Shaheen NJ, Anderson LA, et al. Cigarette smoking increases risk of Barrett’s esophagus: an analysis of the Barrett’s and Esophageal Adenocarcinoma Consortium. Gastroenterology. 2012;142:744–753.PubMedCentralPubMedCrossRefGoogle Scholar
  14. 14.
    Smith KJ, O’Brien SM, Green AC, Webb PM, Whiteman DC. Current and past smoking significantly increase risk for Barrett’s esophagus. Clin Gastroenterol Hepatol. 2009;7:840–848.PubMedCrossRefGoogle Scholar
  15. 15.
    Edelstein ZR, Farrow DC, Bronner MP, Rosen SN, Vaughan TL. Central adiposity and risk of Barrett’s esophagus. Gastroenterology. 2007;133:403–411.PubMedCrossRefGoogle Scholar
  16. 16.
    Anderson LA, Watson RG, Murphy SJ, et al. Risk factors for Barrett’s oesophagus and oesophageal adenocarcinoma: results from the FINBAR study. World J Gastroenterol. 2007;13:1585–1594.PubMedGoogle Scholar
  17. 17.
    Kubo A, Levin TR, Block G, et al. Cigarette smoking and the risk of Barrett’s esophagus. Cancer Causes Control. 2009;20:303–311.PubMedCentralPubMedCrossRefGoogle Scholar
  18. 18.
    Hardikar S, Onstad L, Blount PL, Odze RD, Reid BJ, Vaughan TL. The role of tobacco, alcohol, and obesity in neoplastic progression to esophageal adenocarcinoma: a prospective study of Barrett’s esophagus. PLoS ONE. 2013;8:e52192.PubMedCentralPubMedCrossRefGoogle Scholar
  19. 19.
    Coleman HG, Bhat S, Johnston BT, McManus D, Gavin AT, Murray LJ. Tobacco smoking increases the risk of high-grade dysplasia and cancer among patients with Barrett’s esophagus. Gastroenterology. 2012;142:233–240.PubMedCrossRefGoogle Scholar
  20. 20.
    Ramus JR, Gatenby PA, Caygill CP, Watson A, Winslet MC. The relationship between smoking and severe dysplastic disease in patients with Barrett’s columnar-lined oesophagus. Eur J Cancer Prev. 2012;21:507–510.PubMedCrossRefGoogle Scholar
  21. 21.
    Freedman ND, Murray LJ, Kamangar F, et al. Alcohol intake and risk of oesophageal adenocarcinoma: a pooled analysis from the BEACON consortium. Gut. 2011;60:1029–1037.PubMedCentralPubMedCrossRefGoogle Scholar
  22. 22.
    Steevens J, Schouten LJ, Driessen AL, et al. A prospective cohort study on overweight, smoking, alcohol consumption, and risk of Barrett’s esophagus. Cancer Epidemiol Biomarkers Prev. 2011;20:345–358.PubMedCrossRefGoogle Scholar
  23. 23.
    Anderson LA, Cantwell MM, Watson RG, et al. The association between alcohol and reflux esophagitis, Barrett’s esophagus, and esophageal adenocarcinoma. Gastroenterology. 2009;136:799–805.PubMedCrossRefGoogle Scholar
  24. 24.
    Kubo A, Levin TR, Block G, et al. Alcohol types and sociodemographic characteristics as risk factors for Barrett’s esophagus. Gastroenterology. 2009;136:806–815.PubMedCentralPubMedCrossRefGoogle Scholar
  25. 25.
    Thrift AP, Pandeya N, Smith KJ, et al. Lifetime alcohol consumption and risk of Barrett’s esophagus. Am J Gastroenterol. 2011;106:1220–1230.PubMedCrossRefGoogle Scholar
  26. 26.
    Kramer JR, Fischbach LA, Richardson P, et al. Waist-to-hip ratio, but not body mass index, is associated with an increased risk of Barrett’s esophagus in white men. Clin Gastroenterol Hepatol. 2013;11:373–381.PubMedCrossRefGoogle Scholar
  27. 27.
    Anand O, Wani S, Sharma P. When and how to grade Barrett’s columnar metaplasia: the Prague system. Best Pract Res Clin Gastroenterol. 2008;22:661–669.PubMedCrossRefGoogle Scholar
  28. 28.
    Olliver JR, Hardie LJ, Gong Y, et al. Risk factors, DNA damage, and disease progression in Barrett’s esophagus. Cancer Epidemiol Biomarkers Prev. 2005;14:620–625.PubMedCrossRefGoogle Scholar
  29. 29.
    Pandeya N, Williams G, Green AC, Webb PM, Whiteman DC. Alcohol consumption and the risks of adenocarcinoma and squamous cell carcinoma of the esophagus. Gastroenterology. 2009;136:1215–1224.PubMedCrossRefGoogle Scholar
  30. 30.
    Boffetta P, Hashibe M. Alcohol and cancer. Lancet Oncol. 2006;7:149–156.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Aaron P. Thrift
    • 1
    • 2
    • 6
  • Jennifer R. Kramer
    • 3
    • 4
  • Peter A. Richardson
    • 3
    • 4
  • Hashem B. El-Serag
    • 3
    • 4
    • 5
  1. 1.Cancer Control GroupQIMR Berghofer Medical Research InstituteBrisbaneAustralia
  2. 2.Program in EpidemiologyFred Hutchinson Cancer Research CenterSeattleUSA
  3. 3.Houston VA HSR&D Center of Excellence, Health Services Research and Development ServiceMichael E. DeBakey Veterans Affairs Medical CenterHoustonUSA
  4. 4.Department of MedicineBaylor College of MedicineHoustonUSA
  5. 5.Section of Gastroenterology, Department of MedicineBaylor College of MedicineHoustonUSA
  6. 6.Royal Brisbane HospitalQIMR Berghofer Medical Research InstituteBrisbaneAustralia

Personalised recommendations